SeaStar Medical (NASDAQ:ICU) Announces Quarterly Earnings Results, Beats Expectations By $0.38 EPS

SeaStar Medical (NASDAQ:ICU) posted its quarterly earnings data on Tuesday. The company reported ($1.03) earnings per share for the quarter, topping the consensus estimate of ($1.41) by $0.38, Zacks reports.

SeaStar Medical Trading Up 16.8 %

ICU stock traded up $0.84 during trading on Thursday, hitting $5.85. The company had a trading volume of 124,119 shares, compared to its average volume of 244,287. The firm has a market capitalization of $18.84 million, a price-to-earnings ratio of -0.23 and a beta of -1.07. The business has a 50 day moving average of $7.22 and a 200 day moving average of $13.47. SeaStar Medical has a fifty-two week low of $3.25 and a fifty-two week high of $42.92.

SeaStar Medical Company Profile

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.